SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-073747
Filing Date
2023-06-22
Accepted
2023-06-22 16:08:20
Documents
13
Period of Report
2023-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2319310d1_8k.htm   iXBRL 8-K 54984
2 EXHIBIT 10.1 tm2319310d1_ex10-1.htm EX-10.1 96789
  Complete submission text file 0001104659-23-073747.txt   351023

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20230620.xsd EX-101.SCH 3245
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20230620_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20230620_pre.xml EX-101.PRE 22371
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2319310d1_8k_htm.xml XML 3606
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 231033400
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences